However, in the B16F10 tumor model, which has also been shown to be partially responsive to anti-PD-1 antibody therapy [30], we and others [43] did not observe a significant increase in granzyme B expression after the anti-PD-1 antibody treatment, despite an increased CD8+ cell number. This evidence concerns the gene GZMB and neoplasm.